Surveillance HeartCare® Outcomes Registry

Overview

About this study

The purpose of this study is to assess the clinical utility of surveillance using HeartCare testing services, in association with clinical care of heart transplant recipients.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients who are 15 years of age or older at the time of blood draw.
  • Heart transplant recipients who are selected by their health care provider to be managed with HeartCare.
  • Patients who are selected by their health care provider to be managed following the Heart Routine Testing Schedule (HARTS) or a derivative of the schedule that has been defined by the provider.
  • Patients who provide written informed consent.
  • Patients who have HeartCare initiated within 30 days of signing the informed consent form.

Exclusion Criteria:

  • Patients who are less than 15 years of age at the time of blood draw.
  • Heart transplant recipients who are not managed with HeartCare.
  • Patients who are not managed following the Heart Routine Testing Schedule (HARTS) or a derivative of the schedule that has been defined by the provider.
  • Patients who are pregnant at the time of blood draw.
  • Patients who do not provide written informed consent.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

D Steidley, M.D.

Open for enrollment

Contact information:

Vy Nguyen CCRP

(480) 342-1328

Nguyen.Vy@mayo.edu

Jacksonville, Fla.

Mayo Clinic principal investigator

Juan Carlos Leoni Moreno, M.D.

Contact us for the latest status

Contact information:

Angela Casini MFA

Casini.Angela@mayo.edu

Rochester, Minn.

Mayo Clinic principal investigator

Alfredo Clavell, M.D.

Contact us for the latest status

Contact information:

Julie Gecox Hanson CCRP

(507) 293-6592

Gecox.Julie@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20485444

Mayo Clinic Footer